Clinical differences between atopic and atopiform dermatitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22157

Enrollment

130

Registered

2006-09-07

Start date

2006-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis / Atopiform dermatitis

Interventions

1. Percutaneous skin prik test 2. Phadiatop bloodtest 3. Scorad, EASI 4. Diagnositic criteria: Hanifin and Rajka, UK working party's and Millennium criteria 5. Medical History 6. Quality of life:

Eligibility

Inclusion criteria

Inclusion criteria: 1. Written informed consent; 2. Age: over 2 years old; 3. Male and female patients; 4. Clinical diagnosis of AD; 5. Cases: former negative or unknown allergen-specific IgE levels in blood; 6. Controls: former positive or unknown allergen-specific IgE levels in blood.

Exclusion criteria

Exclusion criteria: 1. Other skin diseases, which interfere the study; 2. Patients unable to comply with the requirements of the study; 3. Treatment with systemic corticosteroids or phototherapy within four weeks before performing the skin prick test; 4. Treatment with oral anti-histamines within 48-hour before performing the skin prick test.

Design outcomes

Primary

Measure	Time frame
AFD (without allergen-specific IgE) is a separate entity with different, specific characteristics compared to AD (with allergen-specific IgE).	—

Secondary

Measure	Time frame
Gain more information about the clinical aspects of AFD.	—

Contacts

Public ContactE.E.A. Brenninkmeijer

Academic Medical Center Amsterdam (AMC) Department of Dermatology, A0-223 P.O. Box 22660

E.E.Brenninkmeijer@amc.uva.nl+31(0)20 5662581

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)